4//SEC Filing
Von Seggern Christopher 4
Accession 0001209191-23-018508
CIK 0001582313other
Filed
Mar 13, 8:00 PM ET
Accepted
Mar 14, 4:47 PM ET
Size
5.3 KB
Accession
0001209191-23-018508
Insider Transaction Report
Form 4
Von Seggern Christopher
Chief Commercial Officer
Transactions
- Award
Stock Option (Right to Buy)
2023-03-10+90,000→ 90,000 totalExercise: $34.18Exp: 2033-03-09→ Common Shares (90,000 underlying)
Footnotes (1)
- [F1]Vesting 25% on January 1, 2024 and 75% vesting thereafter over the course of the next 3 years, in equal amounts, on the last day of each month.
Documents
Issuer
Xenon Pharmaceuticals Inc.
CIK 0001582313
Entity typeother
Related Parties
1- filerCIK 0001821192
Filing Metadata
- Form type
- 4
- Filed
- Mar 13, 8:00 PM ET
- Accepted
- Mar 14, 4:47 PM ET
- Size
- 5.3 KB